Presbyopia

Phentolamine Phase III Data Shows Success in Quickly Reversing Dilation

Roughly half of test subjects—48.9% in one study and 58% in another—saw a return to baseline pupil size within 90 minutes. Hyperemia and discomfort each occurred in about 11% of patients.
09/20/2024

New Daily Multifocal Lens Accommodates More Presbyopes

The “Clariti 1-day Multifocal 3 Add” uses different optical designs for low, medium and high plus powers and offers a wider sphere range than its predecessor.
07/16/2024

Reading Speed, Gaze Behavior Differs Between Types of Presbyopia Correction

Researchers observed variance in head movements between wearers of single-vision contact lenses, multifocal CLs and progressive addition lenses.
04/10/2024

Unhappy Birthday

More trips around the sun means more chances for your patients to develop the dreaded presbyopia.
12/15/2023

Pilocarpine 1.25% Impacts Night Driving

Study shows clinicians should take this into consideration when prescribing the medication to presbyopes.
12/08/2023

FDA Approves Second Presbyopia Drop

A new low-dose pilocarpine agent can be administered up to twice a day for maximum duration of effect. It is hoped to result in fewer adverse effects than Vuity.
10/18/2023

Alcon Adds Multifocal Option to Total30 Line

The company says the new lens is designed to maintain hydration and comfort throughout a month of wear.
10/10/2023

Experts Attempt to Find Consensus on Presbyopic IOL Use

A panel agreed on many aspects of pre-op and intraoperative decision-making. They disagreed, however, when considering issues related to lens selection.
05/31/2023

Vuity Gets Increased Dosing Nod

New, broader latitude for use should overcome some concerns over durability of effect.
03/31/2023

Presbyopia Drugs: A Drop in the Bucket?

With one med available and others coming soon, patients have more options than ever for near vision correction. Do they offer enough to make a difference in a well-established market?
03/15/2023

Upcoming Events

October 29, 2024

Redefine Possibilities For Your Patients and Your Practice
Location: Virtual
Presenters:  Erick Henderson, OD
Webinar: 9:00pm ET

Sponsored by Bausch + Lomb

Register here

November 6, 2024

Showcasing Inflammation and IOP Control
Location: Prime 47
Presenters: Marc Bloomenstein, OD, and Nora Lee Cothran, OD
Time: 7:00pm CT

Sponsored by Bausch + Lomb

Register here

November 13, 2024

Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Harry Boparai, OD, and Doug Katsev, MD
Webinar: 7:00pm PT

Sponsored by Bausch + Lomb

Register here